PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAJ0. A total of 5 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,134,923 | +19.1% | 5,000,000 | 0.0% | 0.21% | +47.9% |
| Q4 2022 | $5,150,000 | +5.0% | 5,000,000 | 0.0% | 0.14% | +4.4% |
| Q3 2022 | $4,904,000 | -0.3% | 5,000,000 | 0.0% | 0.14% | -10.5% |
| Q2 2022 | $4,921,000 | -0.0% | 5,000,000 | 0.0% | 0.15% | +53.5% |
| Q1 2022 | $4,922,000 | +5.8% | 5,000,000 | 0.0% | 0.10% | +4.2% |
| Q4 2021 | $4,652,000 | -8.0% | 5,000,000 | 0.0% | 0.10% | -9.5% |
| Q3 2021 | $5,054,000 | – | 5,000,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITEBOX ADVISORS LLC | 5,000,000 | $6,134,923 | 0.21% |
| UBS OCONNOR LLC | 4,000,000 | $4,720,000 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 15,000,000 | $180 | 0.01% |
| CITIGROUP INC | 2,500,000 | $3,067,475 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |